Global Recombinant Coagulation Factor IX Market Research Report 2025(Status and Outlook)

March 2025 | 158 pages | ID: G9BBEDD9B828EN
Bosson Research

Abstracts

Report Overview

Recombinant Coagulation Factor IX is a biotechnologically engineered protein that plays a crucial role in blood clotting. It is used to treat hemophilia B, a genetic bleeding disorder caused by a deficiency of Factor IX. Recombinant Factor IX is produced in cell cultures using recombinant DNA technology, ensuring a safer and more consistent supply compared to plasma-derived products. This product is administered intravenously to patients with hemophilia B to control and prevent bleeding episodes, manage surgical procedures, and improve their quality of life. Recombinant Coagulation Factor IX has revolutionized the treatment of hemophilia B by providing a more reliable and effective therapeutic option for patients.

The market for Recombinant Coagulation Factor IX is experiencing steady growth driven by several key factors. The increasing prevalence of hemophilia B worldwide is a primary driver of market demand for this product. As awareness about hemophilia B and its treatment options rises, more patients are seeking appropriate care, leading to a higher demand for Recombinant Factor IX. Additionally, advancements in biotechnology and genetic engineering have enabled the development of more efficient and safer recombinant Factor IX products, further fueling market growth. Moreover, the expanding access to healthcare services in developing regions and the growing adoption of recombinant therapies are contributing to the market's positive trajectory. Overall, the market for Recombinant Coagulation Factor IX is poised for continued expansion in the coming years.

This report provides a deep insight into the global Recombinant Coagulation Factor IX market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant Coagulation Factor IX Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant Coagulation Factor IX market in any manner.

Global Recombinant Coagulation Factor IX Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pfizer

Rebinyn

CSL Behring

Takeda

Sanofi

Aptevo Bio Therapeutics

Market Segmentation (by Type)

500 IU

1000 IU

Other

Market Segmentation (by Application)

Adult

Children

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Recombinant Coagulation Factor IX Market
• Overview of the regional outlook of the Recombinant Coagulation Factor IX Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant Coagulation Factor IX Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Recombinant Coagulation Factor IX
1.2 Key Market Segments
1.2.1 Recombinant Coagulation Factor IX Segment by Type
1.2.2 Recombinant Coagulation Factor IX Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Recombinant Coagulation Factor IX Market Overview
2.1 Global Market Overview
2.1.1 Global Recombinant Coagulation Factor IX Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Recombinant Coagulation Factor IX Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Recombinant Coagulation Factor IX Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Recombinant Coagulation Factor IX Product Life Cycle
3.3 Global Recombinant Coagulation Factor IX Sales by Manufacturers (2020-2025)
3.4 Global Recombinant Coagulation Factor IX Revenue Market Share by Manufacturers (2020-2025)
3.5 Recombinant Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Recombinant Coagulation Factor IX Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Recombinant Coagulation Factor IX Manufacturing Sites, Area Served, Product Type
3.8 Recombinant Coagulation Factor IX Market Competitive Situation and Trends
3.8.1 Recombinant Coagulation Factor IX Market Concentration Rate
3.8.2 Global 5 and 10 Largest Recombinant Coagulation Factor IX Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Recombinant Coagulation Factor IX Industry Chain Analysis
4.1 Recombinant Coagulation Factor IX Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Recombinant Coagulation Factor IX Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Recombinant Coagulation Factor IX Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Recombinant Coagulation Factor IX Market
5.7 ESG Ratings of Leading Companies
6 Recombinant Coagulation Factor IX Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant Coagulation Factor IX Sales Market Share by Type (2020-2025)
6.3 Global Recombinant Coagulation Factor IX Market Size Market Share by Type (2020-2025)
6.4 Global Recombinant Coagulation Factor IX Price by Type (2020-2025)
7 Recombinant Coagulation Factor IX Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant Coagulation Factor IX Market Sales by Application (2020-2025)
7.3 Global Recombinant Coagulation Factor IX Market Size (M USD) by Application (2020-2025)
7.4 Global Recombinant Coagulation Factor IX Sales Growth Rate by Application (2020-2025)
8 Recombinant Coagulation Factor IX Market Sales by Region
8.1 Global Recombinant Coagulation Factor IX Sales by Region
8.1.1 Global Recombinant Coagulation Factor IX Sales by Region
8.1.2 Global Recombinant Coagulation Factor IX Sales Market Share by Region
8.2 Global Recombinant Coagulation Factor IX Market Size by Region
8.2.1 Global Recombinant Coagulation Factor IX Market Size by Region
8.2.2 Global Recombinant Coagulation Factor IX Market Size Market Share by Region
8.3 North America
8.3.1 North America Recombinant Coagulation Factor IX Sales by Country
8.3.2 North America Recombinant Coagulation Factor IX Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Recombinant Coagulation Factor IX Sales by Country
8.4.2 Europe Recombinant Coagulation Factor IX Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Recombinant Coagulation Factor IX Sales by Region
8.5.2 Asia Pacific Recombinant Coagulation Factor IX Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Recombinant Coagulation Factor IX Sales by Country
8.6.2 South America Recombinant Coagulation Factor IX Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Recombinant Coagulation Factor IX Sales by Region
8.7.2 Middle East and Africa Recombinant Coagulation Factor IX Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Recombinant Coagulation Factor IX Market Production by Region
9.1 Global Production of Recombinant Coagulation Factor IX by Region(2020-2025)
9.2 Global Recombinant Coagulation Factor IX Revenue Market Share by Region (2020-2025)
9.3 Global Recombinant Coagulation Factor IX Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Recombinant Coagulation Factor IX Production
9.4.1 North America Recombinant Coagulation Factor IX Production Growth Rate (2020-2025)
9.4.2 North America Recombinant Coagulation Factor IX Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Recombinant Coagulation Factor IX Production
9.5.1 Europe Recombinant Coagulation Factor IX Production Growth Rate (2020-2025)
9.5.2 Europe Recombinant Coagulation Factor IX Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Recombinant Coagulation Factor IX Production (2020-2025)
9.6.1 Japan Recombinant Coagulation Factor IX Production Growth Rate (2020-2025)
9.6.2 Japan Recombinant Coagulation Factor IX Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Recombinant Coagulation Factor IX Production (2020-2025)
9.7.1 China Recombinant Coagulation Factor IX Production Growth Rate (2020-2025)
9.7.2 China Recombinant Coagulation Factor IX Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Recombinant Coagulation Factor IX Product Overview
10.1.3 Pfizer Recombinant Coagulation Factor IX Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Rebinyn
10.2.1 Rebinyn Basic Information
10.2.2 Rebinyn Recombinant Coagulation Factor IX Product Overview
10.2.3 Rebinyn Recombinant Coagulation Factor IX Product Market Performance
10.2.4 Rebinyn Business Overview
10.2.5 Rebinyn SWOT Analysis
10.2.6 Rebinyn Recent Developments
10.3 CSL Behring
10.3.1 CSL Behring Basic Information
10.3.2 CSL Behring Recombinant Coagulation Factor IX Product Overview
10.3.3 CSL Behring Recombinant Coagulation Factor IX Product Market Performance
10.3.4 CSL Behring Business Overview
10.3.5 CSL Behring SWOT Analysis
10.3.6 CSL Behring Recent Developments
10.4 Takeda
10.4.1 Takeda Basic Information
10.4.2 Takeda Recombinant Coagulation Factor IX Product Overview
10.4.3 Takeda Recombinant Coagulation Factor IX Product Market Performance
10.4.4 Takeda Business Overview
10.4.5 Takeda Recent Developments
10.5 Sanofi
10.5.1 Sanofi Basic Information
10.5.2 Sanofi Recombinant Coagulation Factor IX Product Overview
10.5.3 Sanofi Recombinant Coagulation Factor IX Product Market Performance
10.5.4 Sanofi Business Overview
10.5.5 Sanofi Recent Developments
10.6 Aptevo Bio Therapeutics
10.6.1 Aptevo Bio Therapeutics Basic Information
10.6.2 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product Overview
10.6.3 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product Market Performance
10.6.4 Aptevo Bio Therapeutics Business Overview
10.6.5 Aptevo Bio Therapeutics Recent Developments
11 Recombinant Coagulation Factor IX Market Forecast by Region
11.1 Global Recombinant Coagulation Factor IX Market Size Forecast
11.2 Global Recombinant Coagulation Factor IX Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Recombinant Coagulation Factor IX Market Size Forecast by Country
11.2.3 Asia Pacific Recombinant Coagulation Factor IX Market Size Forecast by Region
11.2.4 South America Recombinant Coagulation Factor IX Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Recombinant Coagulation Factor IX by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Recombinant Coagulation Factor IX Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Recombinant Coagulation Factor IX by Type (2026-2033)
12.1.2 Global Recombinant Coagulation Factor IX Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Recombinant Coagulation Factor IX by Type (2026-2033)
12.2 Global Recombinant Coagulation Factor IX Market Forecast by Application (2026-2033)
12.2.1 Global Recombinant Coagulation Factor IX Sales (K MT) Forecast by Application
12.2.2 Global Recombinant Coagulation Factor IX Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant Coagulation Factor IX Market Size Comparison by Region (M USD)
Table 5. Global Recombinant Coagulation Factor IX Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Recombinant Coagulation Factor IX Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Recombinant Coagulation Factor IX Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Recombinant Coagulation Factor IX Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Coagulation Factor IX as of 2024)
Table 10. Global Market Recombinant Coagulation Factor IX Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Recombinant Coagulation Factor IX Manufacturing Sites and Area Served
Table 12. Manufacturers Recombinant Coagulation Factor IX Product Type
Table 13. Global Recombinant Coagulation Factor IX Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Recombinant Coagulation Factor IX Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Recombinant Coagulation Factor IX Sales by Type (K MT)
Table 25. Global Recombinant Coagulation Factor IX Market Size by Type (M USD)
Table 26. Global Recombinant Coagulation Factor IX Sales (K MT) by Type (2020-2025)
Table 27. Global Recombinant Coagulation Factor IX Sales Market Share by Type (2020-2025)
Table 28. Global Recombinant Coagulation Factor IX Market Size (M USD) by Type (2020-2025)
Table 29. Global Recombinant Coagulation Factor IX Market Size Share by Type (2020-2025)
Table 30. Global Recombinant Coagulation Factor IX Price (USD/MT) by Type (2020-2025)
Table 31. Global Recombinant Coagulation Factor IX Sales (K MT) by Application
Table 32. Global Recombinant Coagulation Factor IX Market Size by Application
Table 33. Global Recombinant Coagulation Factor IX Sales by Application (2020-2025) & (K MT)
Table 34. Global Recombinant Coagulation Factor IX Sales Market Share by Application (2020-2025)
Table 35. Global Recombinant Coagulation Factor IX Market Size by Application (2020-2025) & (M USD)
Table 36. Global Recombinant Coagulation Factor IX Market Share by Application (2020-2025)
Table 37. Global Recombinant Coagulation Factor IX Sales Growth Rate by Application (2020-2025)
Table 38. Global Recombinant Coagulation Factor IX Sales by Region (2020-2025) & (K MT)
Table 39. Global Recombinant Coagulation Factor IX Sales Market Share by Region (2020-2025)
Table 40. Global Recombinant Coagulation Factor IX Market Size by Region (2020-2025) & (M USD)
Table 41. Global Recombinant Coagulation Factor IX Market Size Market Share by Region (2020-2025)
Table 42. North America Recombinant Coagulation Factor IX Sales by Country (2020-2025) & (K MT)
Table 43. North America Recombinant Coagulation Factor IX Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Recombinant Coagulation Factor IX Sales by Country (2020-2025) & (K MT)
Table 45. Europe Recombinant Coagulation Factor IX Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Recombinant Coagulation Factor IX Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Recombinant Coagulation Factor IX Market Size by Region (2020-2025) & (M USD)
Table 48. South America Recombinant Coagulation Factor IX Sales by Country (2020-2025) & (K MT)
Table 49. South America Recombinant Coagulation Factor IX Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Recombinant Coagulation Factor IX Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Recombinant Coagulation Factor IX Market Size by Region (2020-2025) & (M USD)
Table 52. Global Recombinant Coagulation Factor IX Production (K MT) by Region(2020-2025)
Table 53. Global Recombinant Coagulation Factor IX Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Recombinant Coagulation Factor IX Revenue Market Share by Region (2020-2025)
Table 55. Global Recombinant Coagulation Factor IX Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Recombinant Coagulation Factor IX Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Recombinant Coagulation Factor IX Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Recombinant Coagulation Factor IX Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Recombinant Coagulation Factor IX Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Pfizer Basic Information
Table 61. Pfizer Recombinant Coagulation Factor IX Product Overview
Table 62. Pfizer Recombinant Coagulation Factor IX Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Pfizer Business Overview
Table 64. Pfizer SWOT Analysis
Table 65. Pfizer Recent Developments
Table 66. Rebinyn Basic Information
Table 67. Rebinyn Recombinant Coagulation Factor IX Product Overview
Table 68. Rebinyn Recombinant Coagulation Factor IX Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. Rebinyn Business Overview
Table 70. Rebinyn SWOT Analysis
Table 71. Rebinyn Recent Developments
Table 72. CSL Behring Basic Information
Table 73. CSL Behring Recombinant Coagulation Factor IX Product Overview
Table 74. CSL Behring Recombinant Coagulation Factor IX Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. CSL Behring Business Overview
Table 76. CSL Behring SWOT Analysis
Table 77. CSL Behring Recent Developments
Table 78. Takeda Basic Information
Table 79. Takeda Recombinant Coagulation Factor IX Product Overview
Table 80. Takeda Recombinant Coagulation Factor IX Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Takeda Business Overview
Table 82. Takeda Recent Developments
Table 83. Sanofi Basic Information
Table 84. Sanofi Recombinant Coagulation Factor IX Product Overview
Table 85. Sanofi Recombinant Coagulation Factor IX Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Sanofi Business Overview
Table 87. Sanofi Recent Developments
Table 88. Aptevo Bio Therapeutics Basic Information
Table 89. Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product Overview
Table 90. Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Aptevo Bio Therapeutics Business Overview
Table 92. Aptevo Bio Therapeutics Recent Developments
Table 93. Global Recombinant Coagulation Factor IX Sales Forecast by Region (2026-2033) & (K MT)
Table 94. Global Recombinant Coagulation Factor IX Market Size Forecast by Region (2026-2033) & (M USD)
Table 95. North America Recombinant Coagulation Factor IX Sales Forecast by Country (2026-2033) & (K MT)
Table 96. North America Recombinant Coagulation Factor IX Market Size Forecast by Country (2026-2033) & (M USD)
Table 97. Europe Recombinant Coagulation Factor IX Sales Forecast by Country (2026-2033) & (K MT)
Table 98. Europe Recombinant Coagulation Factor IX Market Size Forecast by Country (2026-2033) & (M USD)
Table 99. Asia Pacific Recombinant Coagulation Factor IX Sales Forecast by Region (2026-2033) & (K MT)
Table 100. Asia Pacific Recombinant Coagulation Factor IX Market Size Forecast by Region (2026-2033) & (M USD)
Table 101. South America Recombinant Coagulation Factor IX Sales Forecast by Country (2026-2033) & (K MT)
Table 102. South America Recombinant Coagulation Factor IX Market Size Forecast by Country (2026-2033) & (M USD)
Table 103. Middle East and Africa Recombinant Coagulation Factor IX Sales Forecast by Country (2026-2033) & (Units)
Table 104. Middle East and Africa Recombinant Coagulation Factor IX Market Size Forecast by Country (2026-2033) & (M USD)
Table 105. Global Recombinant Coagulation Factor IX Sales Forecast by Type (2026-2033) & (K MT)
Table 106. Global Recombinant Coagulation Factor IX Market Size Forecast by Type (2026-2033) & (M USD)
Table 107. Global Recombinant Coagulation Factor IX Price Forecast by Type (2026-2033) & (USD/MT)
Table 108. Global Recombinant Coagulation Factor IX Sales (K MT) Forecast by Application (2026-2033)
Table 109. Global Recombinant Coagulation Factor IX Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Recombinant Coagulation Factor IX
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant Coagulation Factor IX Market Size (M USD), 2024-2033
Figure 5. Global Recombinant Coagulation Factor IX Market Size (M USD) (2020-2033)
Figure 6. Global Recombinant Coagulation Factor IX Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant Coagulation Factor IX Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Recombinant Coagulation Factor IX Product Life Cycle
Figure 13. Recombinant Coagulation Factor IX Sales Share by Manufacturers in 2024
Figure 14. Global Recombinant Coagulation Factor IX Revenue Share by Manufacturers in 2024
Figure 15. Recombinant Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Recombinant Coagulation Factor IX Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Recombinant Coagulation Factor IX Revenue in 2024
Figure 18. Industry Chain Map of Recombinant Coagulation Factor IX
Figure 19. Global Recombinant Coagulation Factor IX Market PEST Analysis
Figure 20. Global Recombinant Coagulation Factor IX Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Recombinant Coagulation Factor IX Market Share by Type
Figure 27. Sales Market Share of Recombinant Coagulation Factor IX by Type (2020-2025)
Figure 28. Sales Market Share of Recombinant Coagulation Factor IX by Type in 2024
Figure 29. Market Size Share of Recombinant Coagulation Factor IX by Type (2020-2025)
Figure 30. Market Size Share of Recombinant Coagulation Factor IX by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Recombinant Coagulation Factor IX Market Share by Application
Figure 33. Global Recombinant Coagulation Factor IX Sales Market Share by Application (2020-2025)
Figure 34. Global Recombinant Coagulation Factor IX Sales Market Share by Application in 2024
Figure 35. Global Recombinant Coagulation Factor IX Market Share by Application (2020-2025)
Figure 36. Global Recombinant Coagulation Factor IX Market Share by Application in 2024
Figure 37. Global Recombinant Coagulation Factor IX Sales Growth Rate by Application (2020-2025)
Figure 38. Global Recombinant Coagulation Factor IX Sales Market Share by Region (2020-2025)
Figure 39. Global Recombinant Coagulation Factor IX Market Size Market Share by Region (2020-2025)
Figure 40. North America Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Recombinant Coagulation Factor IX Sales Market Share by Country in 2024
Figure 43. North America Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Recombinant Coagulation Factor IX Market Size Market Share by Country in 2024
Figure 45. U.S. Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Recombinant Coagulation Factor IX Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Recombinant Coagulation Factor IX Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Recombinant Coagulation Factor IX Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Recombinant Coagulation Factor IX Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Recombinant Coagulation Factor IX Sales Market Share by Country in 2024
Figure 53. Europe Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Recombinant Coagulation Factor IX Market Size Market Share by Country in 2024
Figure 55. Germany Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Recombinant Coagulation Factor IX Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Recombinant Coagulation Factor IX Sales Market Share by Region in 2024
Figure 67. Asia Pacific Recombinant Coagulation Factor IX Market Size Market Share by Region in 2024
Figure 68. China Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Recombinant Coagulation Factor IX Sales and Growth Rate (K MT)
Figure 79. South America Recombinant Coagulation Factor IX Sales Market Share by Country in 2024
Figure 80. South America Recombinant Coagulation Factor IX Market Size and Growth Rate (M USD)
Figure 81. South America Recombinant Coagulation Factor IX Market Size Market Share by Country in 2024
Figure 82. Brazil Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Recombinant Coagulation Factor IX Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Recombinant Coagulation Factor IX Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Recombinant Coagulation Factor IX Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Recombinant Coagulation Factor IX Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Recombinant Coagulation Factor IX Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Recombinant Coagulation Factor IX Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Recombinant Coagulation Factor IX Production Market Share by Region (2020-2025)
Figure 103. North America Recombinant Coagulation Factor IX Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Recombinant Coagulation Factor IX Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Recombinant Coagulation Factor IX Production (K MT) Growth Rate (2020-2025)
Figure 106. China Recombinant Coagulation Factor IX Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Recombinant Coagulation Factor IX Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Recombinant Coagulation Factor IX Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Recombinant Coagulation Factor IX Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Recombinant Coagulation Factor IX Market Share Forecast by Type (2026-2033)
Figure 111. Global Recombinant Coagulation Factor IX Sales Forecast by Application (2026-2033)
Figure 112. Global Recombinant Coagulation Factor IX Market Share Forecast by Application (2026-2033)